Changes in Serum Prostate-Specific Antigen after Treatment with Antibiotics in Patients with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia with Prostatitis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Many urologists have performed prostate biopsy in men with a high level of prostate-specific antigen (PSA) alone. However, high levels of PSA may be induced by infection. We studied the effects of antibiotics on serum total PSA and PSA density (PSAD) in men with total PSA between 4 and 10 ng/ml and normal digital rectal examination (DRE) and transrectal sonographic findings. Materials and Methods: From January 2005 to October 2009, a total of 107 patients with complaints of lower urinary tract symptoms (LUTS) or benign prostatic hyperplasia (BPH) were evaluated. To be included in this study, patients had to be at least 50 years old, have a palpably normal DRE, have infection in the prostate, have a total serum PSA of 4 to 10 ng/ml, and have transrectal ultrasound findings that did not show a hypoechoic lesion in the prostate. Only patients in whom the PSA level was rechecked after short-term antibiotics administration (8 weeks) were included. Serum PSA and PSAD were measured before transrectal ultrasound or EPS and after 8 weeks of treatment with antibiotics (quinolone). Age, prostate volume, serum PSA, PSAD, and PSA rate of change were compared. Results: The mean age of the patients was 66.3 years. The mean prostate size was 48.8±24.9 g. Forty patients had a high level of PSAD. Total PSA and PSAD significantly decreased after treatment (p <0.05). In 45 of the 107 men, total PSA after antibiotics treatment was normalized (less than 4 ng/ml). PSAD after treatment was normalized (less than 0.15 ng/ml/cm3) in 23 of the 40 patients with a high level of PSAD. Conclusion: Antibiotics treatment for at least 8 weeks in BPH patients with an increased PSA level (4-10 ng/ml), infection, and normal DRE and transrectal sonographic findings may decrease serum PSA significantly. However, because the PSA level was not decreased to the normal range (less than 4 ng/ml) in all patients, it seems that antibiotics therapy before prostatic biopsy is not necessary.
Abstract
Purpose: Many urologists have performed prostate biopsy in men with a high level of prostate-specific antigen (PSA) alone. However, high levels of PSA may be induced by infection. We studied the effects of antibiotics on serum total PSA and PSA density (PSAD) in men with total PSA between 4 and 10 ng/ml and normal digital rectal examination (DRE) and transrectal sonographic findings. Materials and Methods: From January 2005 to October 2009, a total of 107 patients with complaints of lower urinary tract symptoms (LUTS) or benign prostatic hyperplasia (BPH) were evaluated. To be included in this study, patients had to be at least 50 years old, have a palpably normal DRE, have infection in the prostate, have a total serum PSA of 4 to 10 ng/ml, and have transrectal ultrasound findings that did not show a hypoechoic lesion in the prostate. Only patients in whom the PSA level was rechecked after short-term antibiotics administration (8 weeks) were included. Serum PSA and PSAD were measured before transrectal ultrasound or EPS and after 8 weeks of treatment with antibiotics (quinolone). Age, prostate volume, serum PSA, PSAD, and PSA rate of change were compared. Results: The mean age of the patients was 66.3 years. The mean prostate size was 48.8±24.9 g. Forty patients had a high level of PSAD. Total PSA and PSAD significantly decreased after treatment (p <0.05). In 45 of the 107 men, total PSA after antibiotics treatment was normalized (less than 4 ng/ml). PSAD after treatment was normalized (less than 0.15 ng/ml/cm3) in 23 of the 40 patients with a high level of PSAD. Conclusion: Antibiotics treatment for at least 8 weeks in BPH patients with an increased PSA level (4-10 ng/ml), infection, and normal DRE and transrectal sonographic findings may decrease serum PSA significantly. However, because the PSA level was not decreased to the normal range (less than 4 ng/ml) in all patients, it seems that antibiotics therapy before prostatic biopsy is not necessary.
참고문헌 (24)
- Landis SH, "Cancer statistics, 1998", CA Cancer J Clin, 48, pp.6~29 (1998)
- Hahnfeld LE, "Prostate cancer", Med Clin North Am, 83, pp.1231~1245 (1999)
- Garnick MB, "Prostate cancer: screening, diagnosis, and management", Ann Intern Med, 118, pp.804~818 (1993)
- Schmidt J, "Trends in pattern of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons", J Urol, 136, pp.416~421 (1986)
- Catalona WJ, "Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men", J Urol, 151, pp.1283~1290 (1994)
- Nadler RB, "Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels", J Urol, 154, pp.407~413 (1995)
- Pansadoro V, "Prostate-specific antigen and prostatitis in men under fifty", Eur Urol, 30, pp.24~27 (1996)
- Cho IR, "PSA and prostatitis in men under 45 years old", Korean J Urol, 39, pp.633~637 (1998)
- Ozden C, "The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis", Int Urol Nephrol, 39, pp.859~863 (2007)
- Baltacı S, "Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen", J Urol, 181, pp.128~132 (2009)
- Hara M, "Some physico-chemical characteristics of "-seminoprotein", an antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretion. VII", Nippon Hoigaku Zasshi, 25, pp.322~324 (1971)
- Wang MC, "Purification of human prostate specific antigen", Invest Urol, 17, pp.159~163 (1979)
- Papsidero LD, "A prostate antigen in sera of prostatic cancer patients", Cancer Res, 40, pp.2428~2432 (1980)
- Lilja H, "Structure, function, and regulation of the enzyme activity of prostate-specific antigen", World J Urol, 11, pp.188~191 (1993)
- Diamandis EP, "Nonprostatic sources of prostate-specific antigen", Urol Clin North Am, 24, pp.275~282 (1997)
- Oesterling JE, "Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate", J Urol, 145, pp.907~923 (1991)
- Stamey TA, "Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate", N Engl J Med, 317, pp.909~916 (1987)
- Tchetgen MB, "effect of prostatitis,urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration", Urol Clin North Am, 24, pp.283~291 (1997)
- Raaijmakers R, "Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam", Urology, 63, pp.316~320 (2004)
- Dalton DL, "Elevated serum prostate-specific antigen due to acute bacterial prostatitis", Urology, 33, pp.465~ (1989)
- Neal DE Jr, "Prostate-specific antigen and prostatitis. I, Effect of prostatitis on serum PSA in the human and non-human primate", Prostate, 20, pp.105~111 (1992)
- Cho IR, "Change of PSA and PSAD after antibiotic treatment in patients with prostatitis", Korean J Androl, 20, pp.100~105 (2002)
- Nickel JC, "The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial", Eur Urol, 54, pp.1379~1384 (2008)
- Grabe M, "Guidelines on urological infections. In: European Association of Urology Guideline 2009 edition", European Association of Urology, 150~166 (2009)